Table of Contents:

1 Report Prologue
2 Executive Summary
3 Market Introduction
3.1 Definition
3.2 Scope of the Study
3.3 Assumptions & Limitations
3.3.1 Assumptions
3.3.2 Limitations
3.4 Market Structure
4 Research Methodology
4.1 Research Process
4.2 Primary Research
4.3 Secondary Research
4.4 Market Size Estimation
4.5 Forecast Model
5 Market Dynamics
5.1 Introduction
5.2 Drivers
5.2.1 Prevalence of chronic kidney disease
5.2.2 Technological advancements in the kidney function testing
5.2.3 Initiatives taken by government to control chronic kidney diseases
5.3 Restraints
5.3.1 False estimates of creatinine testing
5.4 Opportunities
5.4.1 Rising approval from FDA
5.5 Macroeconomic Indicators
6 Market Factor Analysis
6.1 Supply Chain Analysis
6.1.1 R&D
6.1.2 Parts Manufacturing
6.1.3 Distribution
6.1.4 Marketing & Sales
6.1.5 Post-Sales Monitoring
6.2 Demand & Supply: Gap Analysis
6.3 Pricing Analysis
6.4 Investment Opportunities
6.5 Porter's Five Forces Model
6.5.1 Bargaining Power of Suppliers
6.5.2 Bargaining Power of Buyers
6.5.3 Threat of New Entrants
6.5.4 Threat of Substitutes
6.5.5 Intensity of Rivalry
7 Global Creatinine Test Market, by Test Type
7.1 Overview
7.1.1 Blood Test
7.1.2 Urine Test
7.1.3 Creatinine Clearance Test
8 Global Creatinine Test Market, by Product Type
8.1 Overview
8.1.1 Consumables
8.1.2 Instruments
9 Global Creatinine Test Market, By Application
9.1 Overview
9.1.1 Urinary Tract Obstruction
9.1.2 Renal Failure
9.1.3 Kidney Cancer
9.1.4 Glomerulonephritis
10 Global Creatinine Test Market, by End User
10.1 Overview
10.1.1 Hospital & Clinics
10.1.2 Diagnostic Centre
10.1.3 Research Institutes
11 Creatinine Test Market, by Region
11.1 Introduction
11.2 Americas
11.2.1 North America
11.2.1.1 U.S.
11.2.1.2 Canada
11.2.2 South America
11.3 Europe
11.3.1 Western Europe
11.3.1.1 Germany
11.3.1.2 U.K
11.3.1.3 Italy
11.3.1.4 Spain
11.3.1.5 Rest of Western Europe
11.3.2 Eastern Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 Republic of Korea
11.4.6 Rest of Asia Pacific
11.5 The Middle East and Africa
11.5.1 Middle East
11.5.2 Africa
12 Competitive Landscape
12.1 Company Market Share Analysis
12.1.1 Introduction
12.2 Competitive Landscape
12.2.1 Introduction
12.3 Key Developments
13 Company Profiles
13.1 Siemens AG
13.1.1 Company Overview
13.1.2 Financial Overview
13.1.3 Products Offerings
13.1.4 Key Developments
13.1.5 SWOT Analysis
13.1.6 Key Strategy
13.2 Abbott
13.2.1 Company Overview
13.2.2 Financial Overview
13.2.3 Products Offerings
13.2.4 Key Developments
13.2.5 SWOT Analysis
13.2.6 Key Strategy
13.3 Thermo Fisher Scientific Inc
13.3.1 Company Overview
13.3.2 Financial Overview
13.3.3 Products Offerings
13.3.4 Key Developments
13.3.5 SWOT Analysis
13.3.6 Key Strategy
13.4 Abcam plc
13.4.1 Company Overview
13.4.2 Financial Overview
13.4.3 Products Offerings
13.4.4 Key Developments
13.4.5 SWOT Analysis
13.4.6 Key Strategy
13.5 F. Hoffmann-La Roche AG
13.5.1 Company Overview
13.5.2 Financial Overview
13.5.3 Products Offerings
13.5.4 Key Developments
13.5.5 SWOT Analysis
13.5.6 Key Strategy
13.6 Nova Biomedical
13.6.1 Company Overview
13.6.2 Products Offerings
13.6.3 Key Developments
13.6.4 SWOT Analysis
13.6.5 Key Strategy
13.7 ACON Laboratories, Inc.
13.7.1 Company Overview
13.7.2 Products Offerings
13.7.3 Key Developments
13.7.4 SWOT Analysis
13.7.5 Key Strategy
13.8 OPTI Medical Systems
13.8.1 Company Overview
13.8.2 Products Offerings
13.8.3 Key Developments
13.8.4 SWOT Analysis
13.8.5 Key Strategy
13.9 URIT Medical
13.9.1 Company Overview
13.9.2 Products Offerings
13.9.3 Key Developments
13.9.4 SWOT Analysis
13.9.5 Key Strategy
13.1 Quest Diagnostics
13.10.1 Company Overview
13.10.2 Financial Overview
13.10.3 Products Offerings
13.10.4 Key Developments
13.10.5 SWOT Analysis
13.10.6 Key Strategy
13.11 ARKRAY, Inc.
13.11.1 Company Overview
13.11.2 Products Offerings
13.11.3 Key Developments
13.11.4 SWOT Analysis
13.11.5 Key Strategy
13.12 Danaher
13.12.1 Company Overview
13.12.2 Products Offerings
13.12.3 Key Developments
13.12.4 SWOT Analysis
13.12.5 Key Strategy
14 Conclusion
14.1 Key Findings
14.1.1 CEO's Viewpoint
14.1.2 Unmet Needs
14.1.3 Key Companies to Watch
14.1.4 Prediction
15 Appendix
15.1 Discussion Blue Print
15.2 References